llm_output,best_matching_ground_truth,best_evaluation,best_score
venlafaxine comparable to tricyclic antidepressants (tcas),Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.75
The LLM output is partially correct as it mentions venlafaxine instead of monoamine oxidase inhibitors, but accurately states that it is comparable to tricyclic antidepressants in terms of efficacy.",0.75
mirtazapine properties increases serotonin or norepinephrine availability,Mirtazapine Increases Availability of serotonin or norepinephrine (or both),"Score: 0.90
The LLM output correctly conveys the main point of the ground truth statement but lacks some specificity in mentioning both serotonin and norepinephrine.",0.9
selective serotonin reuptake inhibitors (ssris) definition antidepressants that block serotonin reuptake,Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.75
The LLM output partially reflects the ground truth by mentioning reuptake inhibitors, but it inaccurately describes SSRIs as blocking serotonin reuptake when they actually block norepinephrine reuptake.",0.75
vortioxetine specific efficacy in treating depression-related cognitive impairment,"Monoamine oxidase inhibitors Demonstrated specific efficacy in treating Atypical features, such as reactive moods, reverse neuro-vegetative symptoms, and sensitivity to rejection","Score: 0.50
The LLM output is incorrect as it mentions vortioxetine instead of monoamine oxidase inhibitors and focuses on depression-related cognitive impairment rather than atypical features.",0.5
selective serotonin reuptake inhibitors (ssris) comparable to tricyclic antidepressants (tcas),Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.80
The LLM output is mostly correct as it accurately identifies the comparison between SSRIs and TCAs, but it does not mention monoamine oxidase inhibitors, which are the subject of the Ground Truth statement.",0.8
selective serotonin reuptake inhibitors (ssris) first-line treatment major depressive disorder (mdd),Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.75
The LLM output correctly identifies SSRIs as a first-line treatment for major depressive disorder, but misses the mark on norepinephrine reuptake inhibitors as an option for patients who do not respond to SSRIs.",0.75
mirtazapine side effects weight gain,Monoamine oxidase inhibitors Side effects Hepatotoxicity and hypertensive crises,"Score: 0.50
The LLM output is not very relevant to the ground truth, as it mentions a different medication and a different side effect.",0.5
monoamine oxidase inhibitors (maois) less commonly used depression treatment,Pharmacotherapy Entails Monoamine oxidase inhibitors,"Score: 0.75
The LLM output is mostly correct as it mentions monoamine oxidase inhibitors being used for depression treatment, but it incorrectly states that they are less commonly used.",0.75
selective serotonin reuptake inhibitors (ssris) side effects sexual dysfunction,Pharmacotherapy Entails Norepinephrine reuptake inhibitors,"Score: 0.50
The LLM output incorrectly mentions selective serotonin reuptake inhibitors instead of norepinephrine reuptake inhibitors, but correctly identifies a side effect of sexual dysfunction.",0.5
esketamine associated with risk of substance abuse,"Mindfulness-based cognitive therapy Goal Reduce, or even stop, antidepressant treatment without increasing the risk of depressive recurrence, especially for patients at a high risk of relapse","Score: 0.50
The LLM output is somewhat related to antidepressant treatment like the ground truth, but it focuses on a different aspect (risk of substance abuse) rather than the intended goal of reducing or stopping antidepressant treatment for patients with a high risk of relapse.",0.5
monoamine oxidase inhibitors (maois) specific efficacy in treating depression with atypical features,Monoamine oxidase inhibitors Same efficacy as Tricyclic antidepressants,"Score: 0.75
The LLM output is somewhat correct in emphasizing the specific efficacy of MAOIs, but it is not as accurate as the ground truth statement which states that MAOIs have the same efficacy as Tricyclic antidepressants.",0.75
"ketamine side effects neurotoxicity, drug dependence",Monoamine oxidase inhibitors Side effects Hepatotoxicity and hypertensive crises,"Score: 0.50
The LLM output is partially correct as it mentions side effects, but it is incorrect in linking ketamine with hepatotoxicity and hypertensive crises, which are actually associated with monoamine oxidase inhibitors.",0.5
ketamine definition treatment for resistant depression,"Ketamine Has effects on Unipolar, bipolar depression","Score: 0.75
The LLM output is mostly correct as it mentions ketamine as a treatment for resistant depression, but it doesn't specify unipolar and bipolar depression like the ground truth.",0.75
electroconvulsive therapy (ect) highly effective somatic therapy for depression,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM output correctly identifies electroconvulsive therapy (ECT) as an effective somatic therapy for depression, but it misses the other acute-phase treatment options mentioned in the Ground Truth.",0.75
cognitive-behavioral therapy (cbt) first-line treatment major depressive disorder (mdd),"Depression-focused psychotherapy Entails Cognitive-behavioral therapy (CBT), interpersonal therapy (IPT), Supportive therapy (ST) and psychoeducational intervention (PEI)","Score: 0.75
The LLM output is mostly correct as it correctly identifies cognitive-behavioral therapy (CBT) as a key component of depression-focused psychotherapy, but it fails to mention other important therapies such as interpersonal therapy (IPT), supportive therapy (ST), and psychoeducational intervention (PEI).",0.75
bupropion benefits patients with low to moderate level of anxiety,Norepinephrine reuptake inhibitors Eligible for Patients who do not respond to SSRIs,"Score: 0.75
The LLM output is mostly correct in stating that bupropion benefits patients with low to moderate levels of anxiety, but it is not as directly related to the ground truth statement referring to Norepinephrine reuptake inhibitors for patients who do not respond to SSRIs.",0.75
esketamine definition s-enantiomer of ketamine for treatment-resistant depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output provides relevant information about a specific pharmacotherapy for depression, but it does not directly address the treatment of the acute phase of depression as mentioned in the ground truth.",0.75
cognitive-behavioral therapy (cbt) treats resistant depression,Cognitive-behavioral therapy For Depressed patients’ with irrational beliefs and distorted cognitions that perpetuate depressive symptoms by challenging and reversing them,"Score: 0.75
The LLM output is mostly correct as it captures the essence of cognitive-behavioral therapy for treating depression, but it oversimplifies the target population and process compared to the ground truth.",0.75
cognitive-behavioral therapy (cbt) treats elderly depressed patient,Magnetic Seizure Therapy Entials Inducing a therapeutic seizure by applying magnetic stimulation to the brain while the patient is under anesthesia,"Score: 0.75
The LLM output is not highly correct as it incorrectly identifies the treatment as cognitive-behavioral therapy for elderly depressed patients, whereas the ground truth describes Magnetic Seizure Therapy for inducing therapeutic seizures.",0.75
cognitive-behavioral therapy (cbt) treats depression in primary care management,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is mostly correct as it mentions a treatment for depression, but it inaccurately states that CBT is the primary care management, when in reality pharmacotherapy is often the first line of treatment.",0.75
problem-solve therapy (pst) comparable to other psychotherapeutic methods used to treat depression,"Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.75
The LLM output correctly identifies problem-solving therapy as comparable to other psychotherapeutic methods used to treat depression, but does not specifically mention its use in preventing depression among the elderly or treating patients with mild depressive symptoms.",0.75
cognitive-behavioral therapy (cbt) first-line treatment depression in adolescents,"Depression-focused psychotherapy Entails Cognitive-behavioral therapy (CBT), interpersonal therapy (IPT), Supportive therapy (ST) and psychoeducational intervention (PEI)","Score: 0.75
The LLM output correctly identifies cognitive-behavioral therapy (CBT) as a first-line treatment for depression in adolescents, but it does not mention the other components of depression-focused psychotherapy as stated in the ground truth.",0.75
cognitive-behavioral therapy (cbt) first-line treatment depression in children,Cognitive-behavioral therapy Use For the first time treatment,"Score: 0.75
The LLM output captures the essence of the ground truth by mentioning cognitive-behavioral therapy as a first-line treatment, but it adds specifics about treating depression in children which was not mentioned in the ground truth.",0.75
resistant depression treats vagus nerve stimulation (vns),"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output is mostly correct in identifying vagus nerve stimulation as a treatment for resistant depression, but it is missing other somatic treatments and the syntax is not ideal.",0.75
interpersonal therapy (ipt) first-line treatment mild to moderate major depressive episode in adult,Depression-focused psychotherapy For Mild to moderate MDD,"Score: 0.75
LLM Output is mostly correct but could be improved by mentioning ""depression-focused psychotherapy"" specifically rather than just interpersonal therapy as a broader term.",0.75
vagus nerve stimulation (vns) benefits significant positive outcome observe after six to 12 mo,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output is mostly correct but lacks information on other somatic treatments and the specificity of the positive outcomes.",0.75
repetitive transcranial magnetic stimulation (rtms) benefits a well-tolerate profile,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The output correctly identifies rTMS as a somatic treatment but does not mention the other somatic treatments listed in the ground truth statement.",0.75
vagus nerve stimulation (vns) definition a therapeutic method involving the implantation of a pacemaker connected to an electrode surrounding the left vagus nerve,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output correctly defines vagus nerve stimulation but lacks information on other somatic treatments mentioned in the ground truth.",0.75
ketamine treats treatment-resistant major depressive disorder,Schema Therapy Treats Patients with personality disorder comorbidity,"Score: 0.50
The LLM output is only partially correct as it mentions a treatment for a different disorder than the ground truth.",0.5
repetitive transcranial magnetic stimulation (rtms) more effective than placebo conditions with mild side effects and good acceptability,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output is mostly correct in mentioning the effectiveness of repetitive transcranial magnetic stimulation (rTMS) compared to placebo, but it does not fully capture the diverse range of somatic treatments mentioned in the ground truth.",0.75
repetitive transcranial magnetic stimulation example neuro-modulation treatment options for depression,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM output correctly identifies a neuro-modulation treatment option for depression but does not encompass the full range of acute-phase treatment options mentioned in the ground truth.",0.75
esketamine treats treatment-resistant depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.75
The LLM output is mostly correct but not completely, as it specifies a specific type of depression (treatment-resistant) rather than the acute phase of depression as stated in the ground truth.",0.75
selective serotonin reuptake inhibitors (ssris) first-line treatment major depressive disorder,Pharmacotherapy Entails Norepinephrine reuptake inhibitors,"Score: 0.50
The LLM output incorrectly mentions selective serotonin reuptake inhibitors (SSRIs) instead of norepinephrine reuptake inhibitors, leading to a lower overall correctness score.",0.5
transcranial direct current stimulation (tdcs) used as a complementary intervention or as monotherapy to reduce depressive symptoms in unipolar or bipolar depression patients,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output is mostly correct as it accurately identifies transcranial direct current stimulation (tDCS) as a somatic treatment for depression, but it fails to mention other somatic treatments such as rTMS, VNS, DBS, and MST.",0.75
marital and family therapy (mft) treats some aspects of depression,Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.75
The LLM output is mostly correct but lacks specificity in stating that marital and family therapy treat ""some aspects"" of depression instead of specifying severe forms associated with medications and hospitalization.",0.75
intranasal esketamine form of esketamine,Acceptance and commitment therapy Is a form of CBT,"Score: 0.50
The LLM output is incorrect as it is not related to the ground truth statement at all.",0.5
phototherapy benefits effective for both seasonal and non-seasonal depression,Luxtherapy Eligible for Those with seasonal and non-seasonal depression. Benefits to sleep deprivation and drug treatments have also been reported,"Score: 0.75
The LLM output is mostly correct but lacks specificity by not including information about benefits to sleep deprivation and drug treatments.",0.75
exercise treats major depressive disorder (mdd),Schema Therapy Treats Patients with personality disorder comorbidity,"Score: 0.50
The LLM output is not highly correct because it mistakenly substitutes ""exercise"" for ""Schema Therapy"" and it inaccurately claims to treat major depressive disorder instead of personality disorder comorbidity.",0.5
psychotherapy treats major depressive disorder (mdd),Schema Therapy Treats Patients with personality disorder comorbidity,"Score: 0.50
The LLM output is not highly correct as it incorrectly identifies the treatment for major depressive disorder instead of personality disorder comorbidity.",0.5
transcranial direct current stimulation (tdcs) consistency encouraging but vary results that depend on the study’s design and the technique use,"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output correctly mentions transcranial direct current stimulation (tDCS) in relation to somatic treatments, but the lack of mention of other treatments listed in the Ground Truth lowers the overall correctness score.",0.75
"anxious depression more common than nonanxious depression in african american group, hispanics, primary care patients, unemployed, married then divorced/widowed, less, education, public insurance, lower-income","Problem-solving therapy Use Preventing depression among the elderly and treating patients with mild depressive symptoms, especially in primary care","Score: 0.50
The LLM output is partially correct as it describes characteristics related to anxiety and depression in certain demographic groups, but it does not directly address the use of problem-solving therapy for preventing depression among the elderly or treating patients with mild depressive symptoms in primary care.",0.5
"electroconvulsive therapy (ect) highly effective treatment modality for psychiatry, major unipolar depression, and reducing the number of hospital readmissions",Electroconvulsive therapy Reduces Number of hospital readmissions,"Score: 0.85
The LLM output is largely correct, but the addition of more specific information about the effectiveness of ECT for major unipolar depression may slightly reduce the overall correctness score.",0.85
vagus nerve stimulation (vns) second-line treatment treatment-resistant major depressive disorder (trd),"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output correctly identifies vagus nerve stimulation as a second-line treatment for treatment-resistant major depressive disorder (TRD), but misses mentioning other somatic treatments like rTMS, tDCS, DBS, and magnetic seizure therapy.",0.75
cognitive behavioral therapy (cbt) treats major depressive disorder,Cognitive-behavioral therapy For Depressed patients’ with irrational beliefs and distorted cognitions that perpetuate depressive symptoms by challenging and reversing them,"Score: 0.75
The LLM output is mostly correct, but it lacks specificity compared to the ground truth statement which mentions irrational beliefs and distorted cognitions as targets of treatment in cognitive-behavioral therapy for depressed patients.",0.75
"electroconvulsive therapy (ect) recommended for patients with severe and psychotic depression, high risk of suicide, parkinson’s disease, and pregnant patients","Electroconvulsive therapy Eligible for Patients with severe and psychotic depression, a high risk of suicide, or Parkinson’s disease, as well as pregnant patients","Score: 0.95
The LLM output accurately captures the main criteria for eligibility for electroconvulsive therapy, but could be improved by specifying ""eligible for"" instead of ""recommended for"" and adding commas for better clarity.",0.95
psychoeducation treats depression,Pharmacotherapy Treats Acute phase of depression,"Score: 0.50
The LLM Output is only partially correct as psychoeducation can be a component of treating depression but it does not specifically address the acute phase of depression, as stated in the Ground Truth.",0.5
repetitive transcranial magnetic stimulation (rtms) treats major depressive disorder (mdd),"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.75
The LLM output is mostly correct, but it lacks specificity in mentioning other somatic treatments and is limited to only one disorder.",0.75
electroconvulsive therapy (ect) treats major depressive disorder (mdd),Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.75
The LLM output correctly identifies a treatment for major depressive disorder, but it is not the same as marital and family therapy which is more commonly used for severe forms of depression associated with medications and hospitalization.",0.75
"escitalopram more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies escitalopram as more effective than duloxetine, fluoxetine, fluvoxamine, paroxetine, and reboxetine, but misses the comparison to repetitive Transcranial Magnetic Stimulation (rTMS).",0.75
"mirtazapine more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Mirtazapine As effective as SSRIs,"Score: 0.75
LLM output correctly identifies mirtazapine as more effective than SSRIs, but incorrectly includes duloxetine and reboxetine, which are not SSRIs.",0.75
"venlafaxine more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.50
The LLM output correctly identifies specific antidepressants, but does not provide information on repetitive transcranial magnetic stimulation, resulting in only partial correctness.",0.5
"sertraline more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.50
The LLM output correctly identifies a list of antidepressants, but fails to mention repetitive Transcranial magnetic stimulation as being more effective overall.",0.5
reboxetine less effective all tested antidepressants,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output is mostly incorrect as it misrepresents the effectiveness of reboxetine compared to all tested antidepressants, whereas the ground truth states that rTMS is more effective.",0.75
electroconvulsive therapy (ect) associated with reduction in psychiatric readmissions,Electroconvulsive therapy Reduces Number of hospital readmissions,"Score: 0.90
The LLM output captures the essence of the ground truth but uses slightly different wording, resulting in a slightly lower score.",0.9
electroconvulsive therapy (ect) definition the most document and effective method in neuro-modulation treatment for depression,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.75
The LLM output is mostly correct in identifying electroconvulsive therapy as an effective treatment for depression, but it lacks the comprehensive information provided in the ground truth statement.",0.75
ketamine associated with risk of misuse and abuse,Ketamine Has Active metabolite (hydroxynorketamine) that can produce rapid and sustained glutamatergic stimulation,"Score: 0.75
The LLM output is partially correct as it mentions a risk associated with ketamine, but it does not provide a complete or accurate representation of its pharmacological effects.",0.75
major depressive disorder (mdd) definition a mood disorder causing a persistent feeling of sadness and loss of interest,Cognitive-behavioral therapy For Depressed patients’ with irrational beliefs and distorted cognitions that perpetuate depressive symptoms by challenging and reversing them,"Score: 0.75
The LLM output provides a general definition of major depressive disorder but does not specifically address cognitive-behavioral therapy for depressed patients with irrational beliefs and distorted cognitions.",0.75
reboxetine less effective all the other 11 antidepressants,Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly indicates that reboxetine is less effective than the other 11 antidepressants, but it does not fully capture the comparison with repetitive transcranial magnetic stimulation as stated in the ground truth.",0.75
"venlafaxine more effective fluoxetine, fluvoxamine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies the comparison between venlafaxine and fluoxetine/fluvoxamine, but misses mention of rTMS being more effective overall.",0.75
"mirtazapine more effective fluoxetine, venlafaxine",Mirtazapine As effective as SSRIs,"Score: 0.75
The LLM output does not accurately reflect the ground truth statement as it suggests mirtazapine is more effective than specific SSRIs (fluoxetine, venlafaxine) rather than being as effective.",0.75
"escitalopram more effective citalopram, reboxetine, paroxetine, fluoxetine, fluvoxamine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies the effectiveness of different antidepressants compared to each other, but it does not directly mention repetitive Transcranial magnetic stimulation (rTMS).",0.75
escitalopram comparable to sertraline,Nefazodone Is comparable to SSRI,"Score: 0.50
The score is low because while both statements mention that two drugs are comparable, there is a mismatch in the specific drugs mentioned.",0.5
escitalopram highly effective major depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.50
The LLM output only partially captures the information in the ground truth statement, as it mentions a specific medication for major depression but does not address the effectiveness of electroconvulsive therapy in some situations for acute phase depression.",0.5
sertraline highly effective major depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.50
The LLM output is partially correct as it mentions the effectiveness of a medication for major depression, but it does not fully capture the original statement about electroconvulsive therapy for acute phase depression.",0.5
venlafaxine highly effective major depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.25
The LLM output is not very correct as it incorrectly mentions a specific drug (venlafaxine) instead of electroconvulsive therapy and does not capture the nuance of the ground truth statement regarding the effectiveness of ECT in the acute phase of depression in some cases.",0.25
reboxetine not effective major depression,Electroconvulsive therapy Effective Acute phase of depression in some situations,"Score: 0.50
The LLM output is only partially correct as it mentions the ineffectiveness of reboxetine in major depression, but does not address electroconvulsive therapy and its effectiveness in the acute phase of depression.",0.5
mirtazapine highly effective major depression,Mirtazapine As effective as SSRIs,"Score: 0.75
LLM Output partially captures the effectiveness of mirtazapine for major depression, but does not directly compare it to SSRIs as stated in the Ground Truth.",0.75
electroconvulsive therapy (ect) side effects cognitive side effects,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.50
The LLM output correctly identifies one treatment option mentioned in the ground truth but only focuses on side effects, missing the broader range of options and approaches mentioned.",0.5
sertraline comparable to escitalopram,Nefazodone Is comparable to SSRI,"Score: 0.50
The LLM output is partially correct as both statements refer to comparisons of different antidepressants, but they are not directly comparable due to the specific drugs mentioned.",0.5
"sertraline more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine","SSRI Includes fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram","Score: 0.50
The LLM output correctly identifies sertraline as a part of SSRI, but incorrectly compares its effectiveness with other medications in the class.",0.5
"venlafaxine more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies venlafaxine as more effective than other antidepressants mentioned in the ground truth, but misses the mention of rTMS.",0.75
"escitalopram more effective duloxetine, fluoxetine, fluvoxamine, paroxetine, reboxetine",Repetitive Transcranial magnetic stimulation Results rTMS and antidepressants more effective,"Score: 0.75
The LLM output correctly identifies multiple antidepressants as options, but does not provide specific information on their comparative effectiveness in relation to repetitive Transcranial magnetic stimulation as mentioned in the ground truth.",0.75
escitalopram benefits balance between efficacy and acceptability,Fluvoxamine Side effects Lower acceptability due to reduced efficacy,"Score: 0.75
The LLM output is mostly correct as it discusses the balance between efficacy and acceptability of escitalopram, but it does not directly address the topic of fluvoxamine side effects.",0.75
"bupropion, citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, milnacipran, mirtazapine, paroxetine, reboxetine, sertraline, venlafaxine treats unipolar major depression in adults",Pharmacotherapy Treats Acute phase of depression,"Score: 0.80
The LLM output is mostly correct but includes more specific medication names and specifies the condition as unipolar major depression in adults, whereas the ground truth statement is more general and focuses on the acute phase of depression.",0.8
repetitive transcranial magnetic stimulation (rtms) comparable to electroconvulsive therapy (ect),"Somatic treatments Includes Transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy","Score: 0.80
The LLM output is fairly accurate as it correctly identifies rTMS as a type of brain stimulation therapy, but it slightly inaccurately compares it to electroconvulsive therapy (ECT).",0.8
exercise benefits improvement in symptom severity and quality of life in severe mdd,Physical Exercise Benefits Improvements in one’s quality of life,"Score: 0.75
The LLM output correctly identifies the benefits of exercise in improving quality of life, but it specifically mentions symptom severity in severe Major Depressive Disorder which is not explicitly mentioned in the ground truth.",0.75
selective serotonin reuptake inhibitors (ssri) associated with increased risk of sexual dysfunction,"Deep Brain Stimulation Findings Elicited a clinical response in 60% of resistant depression patients after six months and clinical remission in 35% of patients, with benefits maintained for over 12 mo","Score: 0.75
The overall score is 0.75 as the LLM Output is somewhat relevant to the concept of depression treatment but lacks precision in comparison to the Ground Truth statement.",0.75
sertraline recommended starting treatment for moderate to severe unipolar major depression in adults,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.60
The LLM output is somewhat relevant in recommending sertraline for depression, but it does not fully capture the nuanced comparison between bupropion and SSRIs.",0.6
venlafaxine comparable to selective serotonin reuptake inhibitors (ssri) and other antidepressants,Pharmacotherapy Entails Norepinephrine reuptake inhibitors,"Score: 0.75
The LLM output is mostly correct as it mentions venlafaxine, which is a norepinephrine reuptake inhibitor, but it is not entirely accurate as it suggests it is comparable to SSRI's which are not in the same class.",0.75
"all depression definition a mental health disorder characterized by persistently depressed mood or loss of interest in activities, causing significant impairment in daily life",SSRIs Treat Acute phase of depression,"Score: 0.75
The LLM output provides a general definition of depression, but does not specifically address the effectiveness of SSRIs in treating the acute phase of depression as stated in the ground truth.",0.75
anxious depression associated with poor acute outcome following antidepressant treatment,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output is mostly correct in capturing the concept of depression leading to a slower response to treatment, but introduces the idea of anxiety affecting treatment outcome, which is not explicitly mentioned in the ground truth.",0.75
citalopram first-line treatment level 1 of star*d for major depressive disorder,Cognitive-behavioral therapy Use For the first time treatment,"Score: 0.75
The score reflects the similarity in terms of discussing a first-line treatment for a mental health condition but there are inaccuracies in the specific details.",0.75
anxious depression more common than nonanxious depression,Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.50
The LLM output is not directly related to the ground truth statement, resulting in a lower correctness score.",0.5
anxious depression more common than nonanxious depression,Bupropion Finding Is more likely than SSRIs to improve symptoms of fatigue and sleepiness,"Score: 0.50
The LLM output does not directly address the comparison made in the ground truth, resulting in a lower correctness score.",0.5
nonanxious depression definition major depressive disorder without high levels of anxiety symptoms,Cognitive-behavioral therapy For Depressed patients’ with irrational beliefs and distorted cognitions that perpetuate depressive symptoms by challenging and reversing them,"Score: 0.75
The LLM output partially captures the essence of the ground truth by mentioning depression but it fails to accurately describe cognitive-behavioral therapy and the role of irrational beliefs in perpetuating depressive symptoms.",0.75
bupropion benefits patients with depression requiring an antidepressant with fewer sexual side effects,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.75
The LLM output captures the overall benefit of bupropion for patients with depression, but the specific comparison to SSRIs and activation profile mentioned in the Ground Truth statement is missing.",0.75
anxious depression definition major depressive disorder with high levels of anxiety symptoms,Depression-focused psychotherapy Second most common treatment of Acute phase depression,"Score: 0.50
The LLM output does not accurately capture the concept of depression-focused psychotherapy and focuses more on the symptoms of anxious depression.",0.5
anxious depression associated with more medical comorbidity,Schema Therapy Treats Patients with personality disorder comorbidity,"Score: 0.50
The score is lower because the LLM output is not directly related to the ground truth statement; it mentions medical comorbidity instead of personality disorder comorbidity.",0.5
citalopram treats major depressive disorder,Schema Therapy Treats Patients with personality disorder comorbidity,"Score: 0.25
The score is low because the LLM output is completely unrelated to the ground truth, focusing on a different disorder and treatment altogether.",0.25
anxious depression results lower remission rates,"Deep Brain Stimulation Findings Elicited a clinical response in 60% of resistant depression patients after six months and clinical remission in 35% of patients, with benefits maintained for over 12 mo","Score: 0.75
The LLM output is partially correct because it accurately reflects that the remission rates were lower in the study, but it fails to mention the specific findings of deep brain stimulation.",0.75
electroconvulsive therapy (ect) overview usage in the treatment of major depressive disorder and its potential mechanism,"Acute-phase treatment options Approaches Pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT)","Score: 0.80
The LLM output mainly captures the aspect of somatic therapies such as electroconvulsive therapy (ECT) in the treatment of depression, but lacks detail on other acute-phase treatment options mentioned in the ground truth.",0.8
sustain-release bupropion second-line treatment nonremitters to citalopram in level 2 of star*d,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.75
The LLM output is partially correct as it mentions bupropion as a second-line treatment for nonremitters to citalopram, but it does not fully capture the comparison of bupropion with SSRIs mentioned in the Ground Truth statement.",0.75
anxious depression associated with serious adverse psychiatric events,Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.50
The LLM output is partially correct as it mentions depression and psychiatric events, but it inaccurately describes the type of depression being treated.",0.5
anxious depression symptom increased risk of suicidality,SSRIs Treat Acute phase of depression,"Score: 0.75
The LLM output is somewhat related to the ground truth as it discusses depression symptoms, but it lacks specificity in addressing the treatment aspect of SSRIs.",0.75
anxious depression associated with greater overall number of comorbid axis i condition,Pharmacotherapy Treats Acute phase of depression,"Score: 0.50
The LLM output is somewhat related to depression, but it is not directly focused on pharmacotherapy for the acute phase of depression as stated in the ground truth.",0.5
anxious depression associated with greater likelihood of reported suicidal ideation,Depression Side effect Suicidal behavior,"Score: 0.75
The LLM output is mostly correct in capturing the relationship between anxiety, depression, and suicidal ideation, but does not explicitly mention ""side effect"" as stated in the ground truth.",0.75
anxious depression associated with specific treatment responsivity,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output captures the general idea that depression can impact treatment response, but uses different wording and introduces the concept of anxiety, which was not present in the ground truth statement.",0.75
citalopram treats anxious depression symptoms,Marital and family therapy Treats Severe forms of depression associated with medications and hospitalization,"Score: 0.75
The LLM output mentions a specific medication for treating a certain type of depression, which is related to the ground truth of treating depression, but it doesn't fully align with the severe forms of depression associated with medications and hospitalization mentioned in the ground truth.",0.75
serotonin and noradrenaline reuptake inhibitors (snri) definition a class of medication used in the treatment of major depressive disorder that inhibits the reuptake of serotonin and noradrenaline,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.80
The LLM output provides relevant information about serotonin and noradrenaline reuptake inhibitors (SNRIs) but lacks specificity in comparing bupropion to SSRIs for treating major depressive disorder.",0.8
anxious depression associated with poorer treatment outcome with antidepressant monotherapy,Depression Side effect Slower response to treatment,"Score: 0.80
The LLM output is mostly correct in capturing the concept that depression can lead to slower response to treatment, but it adds additional information not present in the ground truth statement.",0.8
"second-generation antidepressants definition a category of medications for major depressive disorder that includes both selective serotonin reuptake inhibitors (ssris) and serotonin and noradrenaline reuptake inhibitors (snris) among others, known for their improved side effect profile over first-generation antidepressants",Depression Side effect Mortality,"Score: 0.75
The LLM output provides a detailed and accurate explanation of second-generation antidepressants, but it does not directly address the connection between depression, side effects, and mortality.",0.75
anxious depression less effective antidepressant treatment in achieving remission compared to nonanxious depression,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output captures the essence of the ground truth by mentioning the slower response to treatment in both cases, but it also introduces the idea of anxious depression affecting the effectiveness of antidepressant treatment.",0.75
"anxious depression associated with higher side effect frequency, intensity, and burden",Depression Side effect Suicidal behavior,"Score: 0.75
The LLM output captures the general relationship between depression and higher side effect frequency, intensity, and burden, but does not specifically mention suicidal behavior as a side effect of depression.",0.75
anxious depression definition a subtype of major depressive disorder with prominent anxiety features,Bupropion Properties Has a more activating profile than SSRIs that are modestly superior to bupropion in patients with MDD,"Score: 0.75
The LLM output is somewhat unrelated to the ground truth statement, as it discusses a subtype of major depressive disorder rather than comparing bupropion to SSRIs.",0.75
"anxious depression side effects greater frequency, intensity, and burden of side effects",Depression Side effect Suicidal behavior,"Score: 0.75
The LLM output partially captured the concept of depression and its side effects, but did not specifically mention suicidal behavior as part of the ground truth.",0.75
anxious depression associated with shorter time in treatment and on the final citalopram dosage,Depression Side effect Slower response to treatment,"Score: 0.75
The LLM output provides relevant information related to depression and treatment response, but mentions anxiety and citalopram which were not present in the ground truth statement.",0.75
